XESG:CA:TSX-iShares ESG Aware MSCI Canada Index ETF (CAD)

ETF | Canadian Equity |

Last Closing

CAD 28.8

Change

-0.11 (-0.38)%

Market Cap

CAD 0.43B

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Canadian Equity

Symbol Name Price(Change) Market Cap
XIU:CA iShares S&P/TSX 60

-0.10 (-0.27%)

CAD 13.94B
XIC:CA iShares Core S&P/TSX Capped Co..

-0.04 (-0.10%)

CAD 13.18B
ZCN:CA BMO S&P/TSX Capped Composite

-0.05 (-0.14%)

CAD 8.49B
VCN:CA Vanguard FTSE Canada All Cap

-0.10 (-0.20%)

CAD 7.69B
ZLB:CA BMO Low Volatility Canadian Eq..

-0.25 (-0.52%)

CAD 3.97B
HXT:CA Global X S&P/TSX 60™ Index ..

-0.12 (-0.19%)

CAD 3.96B
VCE:CA Vanguard FTSE Canada

-0.09 (-0.17%)

CAD 1.96B
QCN:CA Mackenzie Canadian Equity Inde..

-0.68 (-0.46%)

CAD 1.56B
WXM:CA First Asset Morningstar Canada..

-0.02 (-0.07%)

CAD 0.56B
MCLC:CA Manulife Multifactor Canadian ..

-0.06 (-0.15%)

CAD 0.33B

ETFs Containing XESG:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Canadian Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.92% 31% F 60% D-
Dividend Return 2.31% 72% C 53% F
Total Return 16.23% 48% F 62% D
Trailing 12 Months  
Capital Gain 24.03% 28% F 63% D
Dividend Return 3.23% 68% D+ 54% F
Total Return 27.27% 41% F 65% D
Trailing 5 Years  
Capital Gain 44.29% 31% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.29% 10% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.26% N/A N/A 65% D
Dividend Return 10.32% N/A N/A 67% D+
Total Return 2.06% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 14.25% N/A N/A 75% C
Risk Adjusted Return 72.40% N/A N/A 85% B
Market Capitalization 0.43B 68% D+ 57% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.